UNC Metastatic Cancer Radiation Therapy Registry
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 2,000
- 试验地点
- 2
- 主要终点
- Clinical Data
研究概览
简要总结
The purpose of this registry is to collect clinical data from participants attending UNC Hospitals who present with metastatic cancer and are evaluated to receive radiation therapy as part of their standard of care treatment. The goal of this study is to provide a foundation for studies designed to identify projects across the translational continuum related to metastatic cancer and radiation therapy treatment. The relevant clinical data will be linked to patient-reported outcomes (PROs) thus allowing for a unique and robust dataset. Ultimately, this registry will provide current and future studies with the ability to analyze the correlation of radiation therapy regimens with metastatic cancer outcomes.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Written informed consent was obtained to participate in the study and HIPAA
- •Authorization for release of personal health information. Ability to understand and willingness to sign informed consent
- •Diagnosed with or is suspected to have metastatic cancer.
- •Age ≥ 18 years at the time of consent.
- •Evaluated to receive radiation therapy as part of their standard-of-care treatment plan.
排除标准
- •All participants must not meet any of the following exclusion criteria prior to enrollment to participate in this study:
- •Any serious medical or psychiatric disorder that would interfere with the participant's ability to give informed consent.
研究组 & 干预措施
Palliative radiation therapy
Subjects who are with metastatic cancer receive palliative radiation therapy.
干预措施: Radiation therapy (Radiation)
结局指标
主要结局
Clinical Data
时间窗: Up to 1 month
Clinical data and radiological assessments from participants with metastatic cancer receiving radiation therapy as a part of the standard of care will be collected.
次要结局
- Patient reported outcomes (PRO)(Baseline, 1 month, 3 months, 6 months, 9 months, and 12 months)